# Randomized Clinical Trial to Compare a Regimen of Trimethoprim-sulfamethoxazole Plus Rifampicin With a Regimen of Linezolid in the Treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection

> **NCT00711854** · PHASE4 · COMPLETED · sponsor: **University Hospital, Geneva** · enrollment: 150 (actual)

## Conditions studied

- MRSA Infection

## Interventions

- **DRUG:** trimethoprim-sulfamethoxazole (TMP-SMX)
- **DRUG:** Linezolid
- **DRUG:** Rifampicin

## Key facts

- **NCT ID:** NCT00711854
- **Lead sponsor:** University Hospital, Geneva
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2013-12
- **Final completion:** 2014-02
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2014-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00711854

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00711854, "Randomized Clinical Trial to Compare a Regimen of Trimethoprim-sulfamethoxazole Plus Rifampicin With a Regimen of Linezolid in the Treatment of Methicillin-Resistant Staphylococcus Aureus (MRSA) Infection". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00711854. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*